Literature DB >> 8761426

K-ras gene mutation in sputum samples containing atypical cells and adenocarcinoma cells in the lung.

S Shiono1, K Omoe, A Endo.   

Abstract

We analyzed the presence or absence of K-ras mutations in sputum samples with atypical cells by colony hybridization. The frequency of K-ras mutations in 104 patients with adenocarcinoma of the lung was also examined using dot blotting. No mutations in K-ras codon 12 were detected in the 12 sputum samples examined, which included three specimens from patients who later developed lung adenocarcinoma. Because of the paucity of sputum samples, it was difficult to conclude whether K-ras gene mutations are useful for molecular screening for lung cancer at the present time. Secondly, we detected 12 cases [12%; 10 males (19%) and two females (4%)] with a K-ras mutation among 104 patients with lung adenocarcinoma. Although the smoking rate of patients (89%) was higher than the general Japanese male population (approximately 60%), indicating that smoking may be related to the occurrence of adenocarcinoma of the lung, it was unclear whether smoking was related to K-ras mutation from our results. Other factors may contribute to K-ras mutation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8761426     DOI: 10.1093/carcin/17.8.1683

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  3 in total

Review 1.  Sputum examination for early detection of lung cancer.

Authors:  F B J M Thunnissen
Journal:  J Clin Pathol       Date:  2003-11       Impact factor: 3.411

2.  Increased micro-RNA 17, 21, and 192 gene expressions improve early diagnosis in non-small cell lung cancer.

Authors:  Zhan Qi; Da-Yun Yang; Jun Cao
Journal:  Med Oncol       Date:  2014-08-22       Impact factor: 3.064

3.  Lung cancer biomarkers: State of the art.

Authors:  Sangeetha Subramaniam; Ram Krishna Thakur; Vinod Kumar Yadav; Ranjan Nanda; Shantanu Chowdhury; Anurag Agrawal
Journal:  J Carcinog       Date:  2013-02-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.